Pharmaceuticals and Drug Development

Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

Day One Announces FDA Acceptance of NDA and Priority Review for Tovorafenib in Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)

Treatment for: Low-Grade Glioma Day One Announces FDA Acceptance of NDA and Priority Review for Tovorafenib in Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG) BRISBANE, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people […]
Written by
Sociodemographic Disparities Seen in Quality of Life in Children With Hearing Loss
  1. Pharmaceuticals and Drug Development

Sociodemographic Disparities Seen in Quality of Life in Children With Hearing Loss

By Lori Solomon HealthDay Reporter TUESDAY, Oct. 31, 2023 — Race and ethnicity and neighborhood disadvantage are associated with hearing-related quality of life (QOL) in deaf or hard-of-hearing (DHH) children, according to a research letter published online Oct. 30 in JAMA Network Open. Brooke R. Warren, from the University of California in San Francisco, and […]
Written by
  1. Pharmaceuticals and Drug Development

Driving Precision Medicine Forward: Bio-It World Europe Convenes in London 29-30 November 2023

LONDON—To foster collaboration among the UK and Europe’s biopharma and technology leaders who are forging new frontiers in precision medicine, the Bio-IT World Conference & Expo Europe is coming to London 29-30 November 2023.   Held in one of the world’s leading hubs for medical innovation, this annual event will focus on the latest IT […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

FDA Approves Omvoh (mirikizumab-mrkz), a First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis

FDA Approves Omvoh (mirikizumab-mrkz), a First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis INDIANAPOLIS, Oct. 26, 2023 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Omvoh™ (mirikizumab-mrkz) infusion (300 mg/15 mL)/injection (100 mg/mL), the first and only interleukin-23p19 (IL-23p19) antagonist […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

Odronextamab BLA for Treatment of Relapsed/Refractory Follicular Lymphoma (FL) and Diffuse Large B-cell Lymphoma (DLBCL) Accepted for FDA Priority Review

Treatment for: Follicular Lymphoma, Diffuse Large B-Cell Lymphoma Odronextamab BLA for Treatment of Relapsed/Refractory Follicular Lymphoma (FL) and Diffuse Large B-cell Lymphoma (DLBCL) Accepted for FDA Priority Review TARRYTOWN, N.Y., Sept. 29, 2023 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority […]
Written by
TCT: TAVR, SAVR Comparable for Severe Aortic Stenosis, Small Aortic Annulus
  1. Pharmaceuticals and Drug Development

TCT: TAVR, SAVR Comparable for Severe Aortic Stenosis, Small Aortic Annulus

By Elana Gotkine HealthDay Reporter FRIDAY, Oct. 27, 2023 — For patients with severe aortic stenosis (AS) and small aortic annulus (SAA), valve hemodynamic results are comparable with use of transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR), according to a study published online Oct. 26 in Circulation to coincide with the […]
Written by
  1. Pharmaceuticals and Drug Development

Going green in pharmaceuticals

London, 25/10/2023: The pharmaceutical industry is currently responsible for over four per cent of global carbon emissions and this figure is on track to grow in the coming years. The UK Government has committed in legislation to reach net-zero carbon emissions by 2050, but achieving this goal could hinge on whether or not the industry […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

FDA Approves Zymfentra (infliximab-dyyb) Subcutaneous Formulation for the Treatment of People With Inflammatory Bowel Disease

FDA Approves Zymfentra (infliximab-dyyb) Subcutaneous Formulation for the Treatment of People With Inflammatory Bowel Disease JERSEY CITY, N.J.–(BUSINESS WIRE) October 23, 2023 –Today, Celltrion USA announced that the U.S. Food and Drug Administration (FDA) has approved Zymfentra (infliximab-dyyb) for maintenance therapy in adults with moderately to severely active ulcerative colitis (UC) and Crohn’s disease (CD) […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

Basilea Announces FDA Acceptance of New Drug Application for Antibiotic Ceftobiprole

Treatment for: Skin and Structure Infection Basilea Announces FDA Acceptance of New Drug Application for Antibiotic Ceftobiprole Seeking approval for Staphylococcus aureus bacteremia (SAB), acute bacterial skin and skin structure infections (ABSSSI), and community-acquired bacterial pneumonia (CABP) Prescription Drug User Fee Act (PDUFA) goal date set for April 03, 2024 Allschwil, Switzerland, […]
Written by
Study Looks at Palliative Care Use in Adolescents, Young Adults With Cancer
  1. Pharmaceuticals and Drug Development

Study Looks at Palliative Care Use in Adolescents, Young Adults With Cancer

By Elana Gotkine HealthDay Reporter FRIDAY, Oct. 20, 2023 — For adolescents and young adults (AYA) with cancer, the likelihood of receiving specialty palliative care (SPC) is increased for those reporting moderate or severe symptoms, according to a study published online Oct. 20 in JAMA Network Open. Sumit Gupta, M.D., Ph.D., from The Hospital for […]
Written by

Good Reads

700,000 years ahead of their teeth: The carbs that made us human

700,000 years ahead of their teeth: The carbs that made us human

As early humans spread from lush African forests into grasslands, their need for ready sources of energy led them to develop a taste for grassy plants, especially grains and the starchy plant tissue hidden underground. But a new Dartmouth-led study shows that hominins began feasting on these carbohydrate-rich foods before they had the ideal teeth […]
Written by

Dental Stem Cells Differentiate on Biodentine Nanofibers

In a groundbreaking advance within the field of regenerative medicine, researchers have unveiled a novel approach to enhance dental and bone tissue engineering by leveraging the unique properties of dental pulp stem cells (DPSCs) cultured on specially designed polymer nanofibers. The study, recently published in BioMedical Engineering OnLine, explores the odontogenic and osteogenic potential of […]
Written by

Worlwide

700,000 years ahead of their teeth: The carbs that made us human

700,000 years ahead of their teeth: The carbs that made us human

As early humans spread from lush African forests into grasslands, their need for ready sources of energy led them to develop a taste for grassy plants, especially grains and the starchy plant tissue hidden underground. But a new Dartmouth-led study shows that hominins began feasting on these carbohydrate-rich foods before they had the ideal teeth […]
Written by

Dental Stem Cells Differentiate on Biodentine Nanofibers

In a groundbreaking advance within the field of regenerative medicine, researchers have unveiled a novel approach to enhance dental and bone tissue engineering by leveraging the unique properties of dental pulp stem cells (DPSCs) cultured on specially designed polymer nanofibers. The study, recently published in BioMedical Engineering OnLine, explores the odontogenic and osteogenic potential of […]
Written by

Can Tariffs Lead to a More Circular Economy? – State of the Planet

As global trade tensions mount and countries recalibrate their economic priorities, tariffs may have the ability to play an unexpected role in the sustainability conversation. Tariffs on imports, while often viewed as controversial and protectionist weapons, could paradoxically drive the shift not only toward less production, but also toward more localized, circular and environmentally conscious […]
Written by

Trending

Login

Welcome to Life Science News!
"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.